ANGPTL3 and coronary artery disorder: The observed link between EL and CAD is consistent with previous human genetic studies showing the possible harmful effects of a genetically predicted increase in EL activity.59,60 This suggests that ANGPTL3’s interaction with EL might counteract its cardiovascular benefits achieved through LPL inhibition under certain physiological conditions.